Latest Sleep Stories
On May 15, the FDA warned that Eszopiclone Containing Sleep Aids (including Lunesta and generics) can cause next-day impairment of driving and other activities that require alertness.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes.
DUBLIN, May 20, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/t4pr3j/melatonin_market)
Clinically important sleep apnea is common among survivors of acute respiratory failure.
Patient Engagement Can Improve Home Medical Equipment Providers Efficiency SAN DIEGO, May 18, 2014 /PRNewswire/ -- Umbian Inc., a ResMed (NYSE: RMD) company, and leading provider of
Dr. Kaz Zymantas of Premier Dental Center recognizes Better Sleep Month by reminding local residents that he performs sleep apnea treatment in Naperville, IL.
Recent studies by the National Health Institute of Health show that Sleep apnea significantly increases your chances of developing the characteristics of hypertension which can lead to heart failure.
Numerous studies linking obesity to OSA have dentists attending dental continuing education courses with Sleep Group Solutions, to learn screening and treatment methods for snoring and sleep apnea
GLENDALE, Calif., May 16, 2014 /PRNewswire/ -- Glendale sleep apnea expert Dr.
Investment Capital will Fund U.S. Commercialization of the FDA-Approved Inspire Therapy MINNEAPOLIS, May 15, 2014 /PRNewswire/ -- Inspire Medical Systems, Inc.
- A gift; a largess; a gratuity; a present; a dole.
More Images (7 images) »